• 1
    Cantoni GL. Biological methilation: selected aspects. Ann Rev Biochem 1975; 44: 435451.
  • 2
    Chawla RK, Lewis FW, Kutner MH, Batek DM, Roy RGB, Rodman D. Plasma cysteine, cystine and glutathione in cirrhosis. Gastroenterology 1984; 87: 770776.
  • 3
    Arias IM. Mechanism and consequences of iron transport in the liver. In: PopperH, SchaffnerF, eds. Progress in Liver Diseases. New York: Grune & Stratton, 1986: 145159.
  • 4
    Vendemiale G, Altomare E, Trizio T, Le Grazie C, Di Padova C, Salerno MT, Careriera V, et al. Oral S-Adenosyl-L-Methionine on hepatic glutathione in patients with liver cirrhosis. Scand J Gastroenterol 1989; 24: 407415.
  • 5
    Chawla RK, Bonkovsky HL, Galambos JT. Biochemistry and pharmacology of S-adenosyl-L-Methionine and rationale for its use in liver disease. Drugs 1990; 40 (suppl 3): 98110.
  • 6
    Almasio P, Bortolini M, Pagliaro L, Coltorti M. Role of S-Adenosyl-L-Methionine in the the treatment of intrahepatic cholestasis. Drugs 1990; 40 (suppl 3): 111123.
  • 7
    Friedel HA, Goa KL, Benfield P. S-Adenosyl-methionine: a review of its pharmacological properties and therapeutic potential in liver dysfunction and affective disorders in relation to its physiological role in cell metabolism. Drugs 1989; 38: 389416.
  • 8
    Corrales F, Jiménez A, Alvarez L, Caballeria H, Pajares MD, Audreu H, Parés A, et al. S-adenosylmethionine treatment prevents carbon tetra–chloride–induced S-adenosylmethionine synthetase inactivation and attenuates liver injury. Hepatology 1992; 16: 10221027.
  • 9
    Phillips MJ, Poucell J, Oda M. Biology of disease: mechanism of cholestasis. Lab Invest 1986; 54: 593608.
  • 10
    Kountouras J, Barbara H, Billing JS, Billing P. Prolonged bile duct obstruction: a new experimental mode for cirrhosis in rat. Br J Exp Path 1984; 65: 305311.
  • 11
    Posner MC, Burt ME, Stone MD, Han BL, Warren RS, Vydelingrim NA, Brennan MF. A model of reversible obstructive jaundice in the rat. J Surg Res 1990; 48: 204210.
  • 12
    Muriel P, Suarez OR, González P, Zuñiga L. Protective effect of S-adenosyl-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol 1994; 21: 95102.
  • 13
    González–Correa JA, De la Cruz JP, Lucena MI, de la Cuesta F. Sánchez Effect of cyclosporin A on platelet aggregation and thromboxane/ prostacyclin balance in a model of extrahepatic cholestasis in the rat. Thrombosis Res 1996; 81: 367381.
  • 14
    Wassef R, Cohen Z, Lnager B. Pharmacokinetic profiles of cyclosporine in rats: influence of route of administration and dosage. Transplantation 1985; 40: 489494.
  • 15
    Henry RJ, Cannon DC, Winkelman JW. Química clínica. Bases y técnicas. Volume 2. 2nd ed (esp.). Barcelona: JIMS, 1980.
  • 16
    De la Cruz JP, Carrasco T, Ortega G, de la Cuesta F. Sánchez Inhibition of ferrous–induced lipid peroxidation by pyrimido–pyrimidine derivates in human liver membranes. Lipids 1992; 27: 192194.
  • 17
    Bossman HB, Hemsworth BD. In: BurneGA, ed. Structure and Function of Nervous Tissue. 2nd ed. Volume 3. London: Academic Press, 1969: 124.
  • 18
    Lowry O, Rosebrough H, Farr A, Randall R. Protein measurement with the Folin Phenol reagent. J Biol Chem 1951; 193: 265275.
  • 19
    Hissin PJ, Hill R. A fluorimetric method of determination of oxidized and reduced glutathione on tissues. Anal Biochem 1976; 74: 214226.
  • 20
    Flohé L, Gunzler WA. Assays of glutathione peroxidase. Meth Enzymol 1984; 105: 114121.
  • 21
    Warholm M, Guthenberg C, von Bahr C, Mannervik B. Glutathione transferases from human liver. Meth Enzymol 1985; 113: 449503.
  • 22
    Mourelle M, Meza MA. CCl4–induced lipoperoxidation triggers a lethal defect in the liver plasma membranes. J Appl Toxicol 1990; 10: 2327.
  • 23
    Muriel P, Garcia-Pina T, Pérez–Alvarez V, Mourelle M. Silymarin protects against paracetamol–induced lipid peroxidation and liver damage. J Appl Toxicol 1992; 12: 439442.
  • 24
    Muriel P, Favari L, Soto C. Erythrocyte alterations correlate with CCl4 and biliary obstruction–induced liver damage in the rat. Life Sci 1993; 52: 647655.
  • 25
    De la Cruz JP, Gonzalez–Correa JA, Lucena MI, de la Cuesta F. Sánchez Modification of lipid peroxidation in cholestasis rats treated with cyclosporin A. XVIII Congreso de la Sociedad Espanola de Farmacología. Alicante 1994. Methods and Finding. 1994; 16 (suppl 1): 154.
  • 26
    Halliwell B, Gutteridge JMC. Oxygen free radicals and iron relation to biology and medicine: some problems and concepts. Arch Biochem Biophys 1986; 246: 501514.
  • 27
    Skou JC. Overview: the Na, K–pump. Meth Enzymol 1988; 156: 125.
  • 28
    Freel RW, Goldner AM. Sodium coupled ion electrolyte transport across epithelia: emerging concepts and directions. Am J Physiol 1985; 241: G451460.
  • 29
    Pastor A, Collado PC, Almar M, Gonzalez–Gallego J. Microsomal function in biliary obstructed rats: effects of S-adenosyl-methionine. J Hepatol 1996; 24: 353359.
  • 30
    Muriel P, Quintanar ME, Pérez–Alvarez V. Effect of colchicine on acet–aminophen–induced liver damage. Liver 1993; 13: 217221.
  • 31
    Ortiz P, Martin–Duce A, Cabrero C. Phospholipid methylation and S-adenosyl-L-methionine synthesis in human liver cirrhosis. Cell Biol Rev 1987; Sl: 5966.
  • 32
    Belli DC, Fournier L-A, Lepage G, Yousef Y, Roy Cc. S-Adenosylmethio-nine prevents total parenteral nutrition–induced cholestasis in the rat. J Hepatol 1994; 21: 1823.
  • 33
    Owen JS, Rafique S, Osman E, Burroughs AK. Ability of S-Adenosyl-L-methionine to ameliorate lipoprotein–induced membrane lipid abnormalities and cellular dysfunctions in human liver diseases. Drug Inves 1992; 4 (suppl 4): 2240.
  • 34
    Cabrero C, Martin-Duce A, Ortiz P, Alemany S, Mato JM. Specific loss of the high–molecular–weight form of S-adenosyl-L-methionine syntethase in human liver cirrhosis. Hepatology 1988; 8: 15301534.
  • 35
    Martin Duce A, Ortiz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988; 8: 6568.
  • 36
    Corrales F, Cabrero C, Pajares MA, Ortiz P, Martin–Duce A, Mato JM. Inactivation and dissociation of S–Adenosylmethionine Synthetase by modification of Sulfhydryl groups and its possible occurrence in cirrhosis. Hepatology 1990; 11: 216222.
  • 37
    Jover R, Ponsoda X, Fabra R, Trullenque R, Gomez–Lechon MJ, Castell JV. S-Adenosyl-L–methionine prevents intracellulary glutathione deplection by GSH–depleting drugs in rat and human hepatocytes. Drug Inves 1992; 4 (suppl 4): 4653.
  • 38
    Pisi E, Marchesini G. Mechanisms and consequences of the impaired Trans–sulphuration pathway in liver diseases Part II. Clinical consequences and potential for pharmacological intervention in cirrhosis. Drugs 1990; 40 (suppl 3): 6572.
  • 39
    Mosialou E, Ekstrom G, Adang AEP, Morgenstern R. Evidence that rat liver microsomal glutathione transferase is responsible for glutathione–dependent protection against lipid peroxidation. Biochem Pharmacol 1993; 45: 16451651.
  • 40
    Lucena MI, Andrade R, Cabello M, Hidalgo R, Gonzalez–Correa JA, De La Cuesta F. Sanchez Aminoglycosides–associated nephrotoxicity in extrahepatic obstructive jaundice. J Hepatol 1995; 22: 189196.
  • 41
    Desai TK, Tsang TK. Aminoglycoside nephrotoxicity in obstructive jaundice. Am J Med 1988; 85: 4750.
  • 42
    Coratelli P, Passavanti G. Pathophysiology of renal failure in obstructive jaundice. Miner Electrolyte Metab 1990; 16: 6165.
  • 43
    Baumgartner U, Schölmerich J, Weitzel C, Ihling C, Sellinger M, Löhl E, Ruf G, et al. Pattern of bile acid regurgitation and metabolism during perfusion of the bile duct obstructed rat liver. J Hepatol 1995; 22: 208218.
  • 44
    Slott PA, Liu MH, Tavoloni N. Origin, pattern and mechanism of bile duct proliferation following biliary obstruction in the rat. Gastroenterology 1990; 99: 466477.
  • 45
    Dueland S, Reichen J, Everson GT, Davis RA. Regulation of cholesterol and bile acid homeostasis in bile–obstructed rats. Biochem J 1991; 280: 373377.
  • 46
    Wardle EN. Endotoxin and acute renal failure associated with obstructive jaundice. B Med J 1970; 4: 472474.
  • 47
    Warso M, Lands W. Lipid peroxidation in relation to prostacyclin and thromboxane physiology and pathophysiology. Br Med Bull 1983; 39: 277280.
  • 48
    Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium–derived relaxing factor. Nature 1987; 327: 524526.
  • 49
    Coratelli P, Passavanti G, Munno Y, Fumarola D, Amerio A. New trends in hepatorenal syndrome. Kidney Int 1985; 28 (suppl 17): 143147.
  • 50
    Thorn H, Bartolini M, Galli-Kienle M. Anti–ischaemic activity of S-Adenosyl-L-methionine (SAMe) during hypoxia/ reoxygenation in the isolated perfused rat liver. Drug Invest 1992; 4 (suppl 4): 6468.
  • 51
    De La Cruz JP, Gonzalez–Correa JA, Pavia J, Marquez E, de la Cuesta F. Sanchez S-adenosyl-L-methionine inhibits in vitro platelet activation. Meth Find Explt Clin Pharmacol 1995; 17 (Suppl A): P-61.